Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
3SBio Inc.
3SBio Inc. Announces Preliminary Third Quarter 2008 Results
November 22nd, 2008
3SBio Inc. (NASDAQ:SSRX) ("3SBio" or "the Company"), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced that it expects to recognize a one-time impairment charge of approximately RMB19.0 million (US$2.7 million) in the third quarter 2008 and affirmed its 2008 full year guidance. Preliminary Third Quarter 2008 Selected Unaudited Financial Results The Company's financial statements for the three months ended September 30, 2008 have not been finalized and are subject to completion of its normal quarter-end closing procedures. Therefore, the preliminary...
Source: Law & Health Weekly (2008-11-22)
|
